Trans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade Glioma
Clinical trial NCT00826930 · TERMINATED
Trial details
- NCT number
- NCT00826930
- Sponsor
- Diffusion Pharmaceuticals Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2009-05-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.